Melatonin carbon dots and copper inhibit resistant Pseudomonas aeruginosa in tests
Researchers in Mexico developed a melatonin-derived carbon dot and copper(II) chloride nanocomposite that effectively kills multidrug-resistant Pseudomonas aeruginosa and inhibits biofilm formation in lab tests.
Researchers from the University of Guadalajara, Instituto Jalisciense de Cancerología, and Universidad de Guanajuato in Mexico have developed a hydrosoluble nanocomposite that combines melatonin-derived carbon dots with copper(II) chloride. This innovative formulation has shown significant bactericidal activity and effective inhibition of biofilm formation against multidrug-resistant Pseudomonas aeruginosa in laboratory tests.
Pseudomonas aeruginosa is a notorious opportunistic pathogen that causes challenging antibiotic-resistant infections, particularly in healthcare settings. The persistent resistance of this bacterium has prompted researchers to explore alternative therapeutic strategies, including the use of novel molecules and nanomaterials to curb bacterial growth and biofilm development.
The research team synthesized carbon dots directly from melatonin. Thermochemical analysis revealed that these carbon dots spontaneously retained excess melatonin molecules, with a Gibbs free energy change of -1.64 kcal/mol. The carbon dots were then combined with copper chloride to form a hydrosoluble nanocomposite.
To characterize the structural and optical properties of the nanocomposite, the team employed Raman spectroscopy, photoluminescence spectroscopy, Fourier-transform infrared spectroscopy, and electron paramagnetic resonance spectroscopy. Complementary density functional theory calculations were conducted to aid in interpreting the spectral data.
The antibacterial efficacy of the formulations was tested on two bacterial models: the standard reference strain ATCC 27853 and a multidrug-resistant clinical isolate of Pseudomonas aeruginosa. Both strains exhibited strong bactericidal responses and significant suppression of biofilm formation when exposed to the formulations.
Scanning electron microscopy provided direct structural evidence of the treatment's effects, showing clear disruption of cellular structures and confirming the inhibition of biofilm formation after treatment with the composite formulations.
Further biochemical investigations included catalase activity assays, ABTS radical cation scavenging capacity measurements, and LysR-PA2206 expression analysis. These studies indicated strain-dependent redox responses, suggesting that oxidative stress might play a role in the observed antibacterial activity.
The researchers concluded that the carbon dot and melatonin formulations with copper(II) show promise as antimicrobial agents for managing biofilm-associated and antibiotic-resistant Pseudomonas aeruginosa infections.
Source: Emerging Nano Carbons
